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ABSTRACT
Objective: Staphylococcus aureus is a particularly difﬁcult pathogen to eradicate from the respiratory
tract. Previous studies have highlighted the intracellular capacity of S.aureus in several phagocytic
and non-phagocytic cells. The aim of this study was to deﬁne S.aureus interaction within a murine
alveolar macrophage cell line.
Methods: Cell line MH-S was infected with Newman strain. Molecular mechanisms involved in
phagocytosis were explored. To assess whether S.aureus survives intracellularly quantitative
(gentamicin protection assays and bacterial plating) and qualitative analysis (immunoﬂuorescence
microscopy) were performed. Bacterial colocalization with different markers of the endocytic
pathway was examined to characterize its intracellular trafﬁcking.
Results: We found that S.aureus uptake requires host actin polymerization, microtubule assembly
and activation of phosphatidylinositol 3-kinase signaling. Time course experiments showed that
Newman strain was able to persist within macrophages at least until 28.5 h post infection. We
observed that intracellular bacteria are located inside an acidic subcellular compartment, which co-
localizes with the late endosome/lysosome markers Lamp-1, Rab7 and RILP. Colocalization counts
with TMR-dextran might reﬂect a balance between bacterial killing and intracellular survival.
Conclusions: This study indicates that S.aureus persists and replicates inside murine alveolar
macrophages, representing a privileged niche that can potentially offer protection from antimicrobial
activity and immunological host defense mechanisms.
KEYWORDS
invasion; macrophage;
persistence; phagocytosis;
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Introduction
Staphylococcus aureus is an important human pathogen
in both community and hospital settings. Infections can
involve any organ system and can range from asymp-
tomatic colonization to virulent forms of septicemia.1
The ability to cause such a wide range of infections is the
result of its wide repertoire of virulence factors2 and
strategies that evade recognition by the innate immune
system.3 Resistance of S. aureus to methicillin and other
current available treatments is increasing, becoming an
important clinical problem.4
Although skin and soft tissue infections represent the
major burden of staphylococcal disease, infections of the
bloodstream and lower respiratory tract are of major
interest because of the associated high morbidity and
mortality and prolonged treatment requirements.5 Respi-
ratory tract is a major reservoir of both methicillin sus-
ceptible and methicillin resistant S aureus (MRSA).6,7 S.
aureus is a major cause of pneumonia following Inﬂu-
enza and is one of the most frequent etiological agents of
ventilator associated pneumonia.8,9
Resident alveolar macrophages play a critical role in the
clearance of bacteria from the lung by their capacity for
phagocytosis and killing. This process can be conceptually
divided into the phagosome formation and subsequent
evolution into a degradative compartment, through the
phagosome maturation process whereby the phagosome
gains microbicidal activity. Macrophage maturation aids
clearing infection, and at the same time it generates route
antigens for presentation on MHC molecules to activate
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the adaptive immune system.10 Phagosomematuration is a
process that involves sequential fusions and interactions
with sub-compartments of the endocytic pathway.11 This
maturation process is characterized by the acquisition of
different proteins, such as antigens, GTPases, proteases,
and ATPase in a choreographed sequence of events that
culminates with the formation of the phagolysosome.12
Some pathogens have developed strategies to counter-
act the microbicidal effect of macrophages. These mecha-
nisms include: inhibition of phagocytosis by preventing
opsonophagocytosis or blocking speciﬁc signaling path-
ways,13 avoiding delivery to the lysosome, and release in
the cytoplasm, as is the case for Listeria monocytogenes14
or arresting phagosome maturation, creating an optimal
niche for replication, an essential feature of Mycobacte-
rium tuberculosis survival.15
There is accumulating evidence that S. aureus is able
to survive within eukaryotic host cells, both professional
phagocytes, and non-professional phagocytes.16 This
intracellular stage may be crucial for persistence, dissem-
ination and infection of distant anatomic sites using
phagocytes as a ‘Trojan horse’ delivery system.17 The
role of neutrophils in innate host defense against S.
aureus infections, and strategies to circumvent their
function are being extensively investigated.18,19 In the
same direction, there is interest in exploring the interplay
between S.aureus and macrophages.20-23 Regarding
staphylococcal lower respiratory tract infections, the
murine model of pneumonia is the most explored one,24
and the evaluation of speciﬁc antibodies targeting viru-
lence factors secreted during pneumonia is currently
under investigation.25 So, exploring an in-vitro model
using alveolar macrophage cell line can also be a valuable
approach, as shown for Legionella pneumophila.26
A focus on exploring MRSA impact and importance dur-
ing carriage and lung infections is justiﬁable, although
the role of methicillin susceptible strains need also to be
considered. Indeed persistent isolation of S.aureus in
respiratory clinical samples has been reported regardless
of cloxacillin resistance.27 Thus, to have a better under-
standing of the host-pathogen interaction speciﬁcally in
the lower respiratory tract, one important aspect is to
focus on S.aureus interaction with alveolar macrophage.
Thus, the objective of our study was to deﬁne the
intracellular life style of S.aureus in an experimental
infection model with a murine alveolar cell line.
Results
S.aureus survives inside murine macrophages
To investigate the molecular mechanisms used by MH-S
to engulf S.aureus, infections were performed in the
presence of drugs that inhibit speciﬁc host cell functions.
Cytochalasin D (Cyt D) (prevents actin polymerization)
and nocodazol (affects microtubule polymerization) sig-
niﬁcantly reduced bacterial engulfment, indicating that
phagocytosis process requires the correct assembly of
host F-actin and microtubule network. Depletion of cellu-
lar cholesterol with cholesterol-binding reagents, such as
methyl-b-cyclodextrin (MbCD), nystatin, or ﬁlipin,
slightly decreased bacterial phagocytosis but only nystatin
pre-incubation reached statistical signiﬁcance, as shown
in Fig. 1(a). Since the generation of phosphoinositides is
linked to the phagosome formation,28 we evaluated the
contribution of phosphatidylinositol 3-kinase contribu-
tion (PI3K) signaling pathway on S.aureus phagocytosis.
Pre-treatment of MH-S with LY294002, a speciﬁc inhibi-
tor of PI3K activity, resulted in a decreased bacterial
count, indicating phagocytosis blockage.
To determine the fate of S.aureus once inside MH-
S macrophages, intracellular bacteria were assessed by
the gentamicin protection assay following differing
incubation periods and microscopically using differ-
ential staining. Results indicate that macrophages
were able to engulf S.aureus, and that once inside the
macrophage, S.aureus was able to survive intracellu-
larly [Fig. 1(b)]. The increase for the earliest time
point to the last one was statistically signiﬁcant
(p < 0.05). Although the number of intracellular bac-
teria in MH-S macrophages decreased during the ﬁrst
hour post infection, counts remained constant till
16.5 h post infection. From that time point, there was
an increase in the number of intracellular bacteria up
to 28.5 h post infection that was the last time point
considered.
Given that antibiotics can be internalized and deliv-
ered to terminal lysosomes as phagocytosed bacteria,22
the experiment was also performed in the absence of
gentamycin (25 mg/ml) for the long-term incubation
periods, to ensure that the presence of antibiotic was not
affecting intracellular bacteria (Fig 1b). Intracellular bac-
terial counts showed a similar trend between conditions,
thus the observations presented are due to S. aureus biol-
ogy, and not to experimental design.
Microscopy analysis revealed that the percentage of
infected macrophages was similar during the time
course, suggesting the absence of re-infections [Fig. 1
(c)]. The number of macrophages containing 1 to 2 bac-
teria decreased along time [Fig. 1(d)]. The number of
macrophages containing between 3 and 5 bacteria tend
to decrease slightly along time. In contrast, the number
of macrophages containing more than 5 bacteria
increased, suggesting the microorganism was not only
able to survive, but also to replicate inside macrophages
[Fig. 1(e)]. We also analyzed whether S.aureus exerts a
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cytotoxic effect on macrophages. For that, we estimated
the viability of infected MH-S cells by the neutral red
uptake assay.29 S.aureus infection was associated with a
slight increased cell death from 18 h post-infection that
reached 20% cell death after 24 h post infection
[Fig. 1(f)]. The experiment was also performed in the
absence of antibiotic for long-term incubation. Results
show, that in the absence of gentamycin, the increase in
cytotoxicity begins at 6 h post-infection, reaching similar
values at 24 h.
Collectively, these results show that Newman strain is
able to survive and replicate within MH-S and that the
phagocytosis process is an event dependent on host cyto-
skeleton and PI3K/Akt signaling pathway.
S.aureus subcellular localization
Since S.aureus is able to survive within macrophages,
we hypothesized that it could inhibit or divert the
normal process of phagosome maturation or
Figure 1. (For ﬁgure legend, see page 1764.)
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withstand in the hostile environment of a mature
phagolysosome. We examined the presence of
markers speciﬁc of the consecutive sub-compartments
of the endocytic pathway, on the S.aureus containing
compartment. Early endosome antigen 1 (EEA-1) is
an endosome-speciﬁc peripheral membrane protein
found in early phagosomes.11 As shown in Fig. 2(a),
we detected the presence of EEA-1 on 40% of phago-
somes at 30 min post infection. The overlap of the
phagosome containing S. aureus with this marker
dropped to 20% from 45 min post infection. We then
sought to determine whether the phagosome acquires
late endosomal markers such as lysosome-associated
membrane protein 1 (Lamp-1) and Rab7. At 0.5 h
post infection, Lamp-1 was detected on almost 50%
of S.aureus containing phagosomes. At 1.5h post
infection, the percentage increased up to 80%. From
that moment and until the last time point considered,
the percentage of colocalization remained constant at
100%. [Fig. 2(b)]. Rab7 is another characteristic
marker of late phagosome. It is a small G-protein
that controls vesicular transport between phagosomes
and late endosomes or lysosomes in the endocytic
pathway.11 Almost 100% of S.aureus containing phag-
osomes were positive for GFP-Rab7 since 1.5 h post-
infection [Fig. 2(c)]. To determine the activation sta-
tus of Rab 7, cells were transfected with a plasmid
containing GFP fused to the C-terminal Rab7-binding
domain of Rab-interacting lysosomal protein (RILP),
named RILP-C33. RILP is a Rab7 effector protein
that exclusively recognizes the active conformation of
Rab7 (bound to GTP). As shown in Fig. 2(d), RILP-
C33-GFP co-localized with the majority of S.aureus
containing phagosomes at all time points analyzed.
Since the interaction of Rab7 with RILP drives
fusion with lysosomes,30,31 we sought to determine
whether S.aureus containing compartment co-localizes
with lysosomal markers. Although there are no
markers that can unambiguously distinguish late endo-
somes from lysosomes, mounting/existing evidence
indicates that an acidic luminal pH is characteristic of
the phagolysosomal fusion.11,32 We used the ﬁxable
acidotropic probe lysotracker to monitor acidic organ-
elles. We found a major overlap between the dye and
the S.aureus containing phagosome. At 1.5 h post
infection the percentage of colocalization was 75% and
from 21.5h post infection till last time analyzed it was
100%. These results hence indicate that the compart-
ment is acidic [Fig. 3(a)]. To further evaluate whether
compartments of the endocytic pathway, including
lysosomes were involved in the phagosome matura-
tion, we assessed the colocalization of bacteria contain-
ing compartment with tetramethylrhodamine-labeled
dextran (TMR-dextran). Prior to bacterial infection,
macrophages were pulsed with TMR-dextran for 2 h
followed by 1h chase in dye-free medium to ensure
that the probe was delivered from early and recycling
endosomes to lysosomes. Pulse-chase protocols with
TMR-dextran are extensively used in the literature to
label lysosomes.33 We observed that at 1.5 h and 3.5 h
post infection, 26% and 37% of compartments co-
localized with TMR-dextran [Fig. 3(b)]. At 5.5h and
24.5h post infection, 47% of the intracellular S.aureus
co-localized with TMR-dextran, suggesting that phago-
somes containing S.aureus either partially prevent
phagolysosome delivery, or rather delay it. When incu-
bating macrophages with UV-killed S.aureus, almost
65% of S.aureus containing phagosome already co-
Figure 1. (see previous page) Phagocytosis and dynamics of Newman S.aureus survival in MH-S. (a) Molecular mechanisms involved on
S.aureus phagocytosis by MH-S cells. Eukaryotic cells were left untreated or pre-treated for 1 h with nocodazole, MbCD, nystatin, ﬁlipin
or LY294002 and for 30 min with Cyt D. Cells were then infected for 30 min, and after 1 hour treatment with gentamicin (200 mg/ml),
bacterial uptake was quantiﬁed by cell lysis, serial dilution and viable counting on LB agar plates. Results are expressed in c.f.u. per well.
Data are representative of 3 independent experiments. , p < 0.05 results are signiﬁcantly different from the ones for untreated cells
(control). (b) Time course analysis of intracellular S. aureus Newman in infected MH-S. Cells were infected for 30 min (MOI 25:1). Wells
were later washed and incubated with medium containing gentamicin (200 mg/ml) for 1 h to eliminate extracellular bacteria, and then
with medium containing gentamicin (25 mg/ml) (white) or media without gentamicin (black) for up to 28.5 h. Intracellular bacteria
were quantiﬁed by lysis, serial dilution and viable counting on LB agar plate. Log 10 c.f.u./well are the average of at 6 independent
experiments. p < 0.05 results are signiﬁcantly different between time points, for both conditions. (c) MH-S cells were infected with S.
aureus as described above and the percentage of macrophages containing intracellular bacteria was assessed over time. At least 300
cells belonging to 3 independent experiments were counted per time point considered. (d) Percentage of infected macrophages con-
taining one to 2, 3 to 5 or more than 5 intracellular bacteria (determined by extra and intracellular differential staining) over time. At
least 300 cells belonging to 3 independent experiments were counted per time point considered. (e). Representative immunoﬂuores-
cence analysis of infected MH-S. Image was taken at 3.5 h post infection and shows nuclei stained with Hoeschst 33342 (blue), actin
cytoskeleton stained with rhodamine-phaloidin (red) and S.aureus stained with secondary antibody conjugated to Cy2 (green). (f)
Cytotoxicity in S.aureus infected MH-S. Cells were infected with a MOI of 25:1. After 30 min of contact, wells were washed and later incu-
bated with gentamicin (200 mg/ml) (white) or media without gentamicin (black) until 24 h. At speciﬁc time points, cell viability was
determined by means of neutral red uptake assay. Experiments were performed by triplicate in 3 independent occasions, p < 0.05. All
comparisons were statistically signiﬁcant when comparing values obtained in the presence of antibiotic. Statistical signiﬁcant differences
were observed between 6 h and 18 h for those wells without antibiotic.
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Figure 2. Phagosome maturation during S.aureus infection. (a) Percentage of colocalization of S.aureus and the early endosomal marker
EEA-1 over a time course (images were taken 0.5 h post infection). S.aureus was stained with rabbit anti-S.aureus and Cy2-conjugated
donkey anti-rabbit (green) antibodies. EEA1 was stained with goat anti-EEA1 and rhodamine-conjugated donkey anti-goat (red) anti-
bodies. (b) Percentage of colocalization of S.aureus and Lamp-1 over a time course (images were taken 24.5 h post infection). S.aureus
was stained with rabbit anti-S.aureus and Cy2-conjugated donkey anti-rabbit (green) antibodies. Lamp-1 was stained with mouse anti-
lamp-1 and rhodamine-conjugated donkey anti-rat antibodies. (c) Percentage of colocalization of S.aureus and GFP-Rab7 over a time
course (images were taken 1.5h post infection). Cells were transfected 24 h before the experiment with GFP-Rab7. S.aureus was stained
with rabbit anti-S.aureus and texas red-conjugated donkey anti-rabbit (red) antibodies. (d) Percentage of colocalization of S.aureus and
RILP-C33-EGFP over a time course (images were taken 3.5 h post infection). Cells were transfected 24 h before the experiment with
RILP-C33-EGFP. S.aureus was stained with rabbit anti-S.aureus and texas red-conjugated donkey anti-rabbit (red) antibodies. Images are
representative of triplicate coverslips in 3 independent experiments. At least 300 infected cells belonging to 3 independent experiments
were counted per marker and time point considered.
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localized with TMR-dextran after 15 and 30 min post
infection.
Collectively, these ﬁndings suggest that S.aureus traf-
ﬁcked across classical endocytic pathway, but delay its
phagolysosomal fusion.
Inhibition of compartment acidiﬁcation does not
affect S.aureus intracellular survival
Phagosome acidiﬁcation has been shown to be essential
for the intracellular survival of some pathogens.34,35
Therefore, since we have localized S.aureus inside acidic
compartment, we investigated the effect of inhibiting
compartment acidiﬁcation on S.aureus survival. Baﬁlo-
mycin A1 is a speciﬁc inhibitor of the vacuolar type H
C-
ATPase (V-ATPase) that inhibits the acidiﬁcation of
organelles containing this enzyme, such as lysosomes
and endosomes. To assess the effect of vacuolar acidiﬁca-
tion on intracellular S.aureus survival, cells were treated
with baﬁlomycin A1 (100 nM) at the onset of gentamicin
treatment and bacteria were enumerated by plating at
different time points [Fig. 4(a)]. Results show that
although there is a slight decrease of bacterial number
when comparing baﬁlomycin treated vs DMSO (regard-
less of the time point selected), S.aureus is able to persist
in baﬁlomycin treated cells. Compartment acidiﬁcation
was sensitive to baﬁlomycin A1, thereby lysotracker
staining was removed conﬁrming dependence on the cel-
lular vacuolar HC-ATPase [Fig. 4(b)]. Altogether, these
observations suggest that compartment acidiﬁcation is
not critical for survival.
Rab 14 and PI3K/Akt axis
At least 18 Rab GTPases have been implicated in phago-
somal maturation. Interestingly, some microorganisms
such as Salmonella, M.tuberculosis, and Klebsiella pneu-
moniae target Rab14 to prevent phagosomal matura-
tion.36-38 To explore whether S.aureus may also target
Rab14 to control the phagosome maturation, we monitor
Rab14 by infecting MH-S with GFP-Newman and later
staining coverslips with anti-Rab14 antibody. However,
no colocalization was detected from 0.5 h to 5.5 h
post-infection [Fig. 5(a)]. Given that Rab recruitment
can be transient and thus difﬁcult to assess, and that
phagosomes containing S. aureus partially prevented or
delayed phagolysosome delivery to lysosomes, we also
explored the potential implication of Rab14 using
transfection experiments. Cells were transfected with a
Rab14 dominant-negative construct (DN-Rab14) or con-
trol vector (pcDNA3) and later infected with Newman
strain. As shown in Fig. 5(b), bacterial counts were
statistically lower in cells transfected with DN-Rab14
plasmid in comparison to pcDNA3 transfected cells at
Figure 3. Colocalization of S.aureus with phagolysosomal markers. (a) Percentage of colocalization of S.aureus inside acidic compart-
ments over a time course (images were taken 1.5 h post infection). S.aureus was stained with rabbit anti-S.aureus and Cy2-conjugated
donkey anti-rabbit (green) antibodies. Acidic compartments were loaded with lysotracker (red). (b) Percentage of colocalization of
S.aureus with TMR-dextran (red) over a time course (images were taken 3.5 h post infection). Cells were pulse–chased with TMR-dextran,
then infected and ﬁxed at the indicated times. S.aureus was stained with rabbit anti-S.aureus and Cy2-conjugated donkey anti-rabbit
(green) antibodies.
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all time points considered, suggesting that the overex-
pression of inactive Rab14 enabled almost a complete
phagolysosome maturation and therefore elimination of
intracellular S.aureus. To conﬁrm these results micro-
scopically, we assessed colocalization of TMR-dextran in
transfected cells with both plasmids. As expected the per-
centage of colocalization was higher in DN-Rab14 trans-
fected cells (62.9% at 1.5 h post infection and 61.7% at
3.5 h post infection) in comparison to control conditions
(36.8% at 1.5 h and 53.9% at 3.5 h) [Fig. 5 (c)].
Several pathogens target the PI3K-Akt axis to manip-
ulate intracellular trafﬁcking on their own beneﬁt.39 This
is because Akt inactivates the Rab14 GTPase activator,
named AS160 thereby preventing AS160 recruitment to
the phagosomal membrane. This fact extends Rab14 acti-
vation, avoiding phagosome maturation.39-41 We have
previously shown that PI3K is necessary for S.aureus
internalization. As PI3K has been also related with phag-
osome maturation,28 we further explored whether PI3K
had a role during intracellular trafﬁcking of S. aureus
containing phagosome. Akt is a downstream effector of
PI3K, which becomes phosphorylated upon activation of
the PI3K signaling cascade. Western blot analysis
revealed that S.aureus infection process induced Akt acti-
vation (P-Akt) in a PI3K-dependent manner [Fig. 5(d)],
and LY294002 administration during gentamicin treat-
ment inhibited Akt phosphorylation. Additionally,
Western blot analysis also showed that infection with
S.aureus triggered the phosphorylation of AS-160 in a
PI3K-Akt dependant manner, since the presence of
LY294002 inhibitor prevented S.aureus-induced AS-160
phosphorylation [Fig. 5(d)].
We next sought to determine the particular contribu-
tion of PI3K-Akt axis to the intracellular survival of
S.aureus. Inhibition of PI3K-Akt axis did not affect intra-
cellular survival counts. Treatment of cells with PI3K
inhibitor, LY294002 after the time of contact did not
affect the number of intracellular bacteria recovered at
the 4 time points considered, as compared with non
treated cells as similar bacterial counts were obtained.
Similarly, treatment of cells with the Akt inhibitor (AKT
X) did not reduce the intracellular bacterial counts, as
shown in Fig. 5 (e). Collectively, these results suggest
that PI3K-Akt signaling pathway is not relevant for the
survival of S.aureus once inside the macrophage.
Discussion
In the present study we provide evidences showing that
Newman S.aureus survives inside within murine alveolar
macrophages in a time course experiment and have char-
acterized its intracellular trafﬁcking.
The infection rate was relatively high and constant
during the time course. S.aureus is indeed a prototype
of pyogenic pathogen with a great ability to adhere
and invade tissues. The phagocytosis of S.aureus
within murine macrophages involved the reorganiza-
tion of actin cytoskeleton, as well as the activation of
PI3K signaling pathway.32 The same signaling path-
way was also involved in internalization of S.aureus
in bovine endothelial cells42; suggesting that the
mechanism is somehow common for phagocytic and
non-phagocytic cells. Once inside the macrophage,
Newman S.aureus strain was found to be viable at
Figure 4. Importance of vacuolar acidiﬁcation on S.aureus survival (a) Effect of baﬁlomycin on intracellular bacterial counts. MH-S were
treated with baﬁlomycin A1 (100 nM) at the onset of gentamicin treatment and bacteria were quantiﬁed by lysis, serial dilution and via-
ble counting on LB agar plates. Data, shown as c.f.u./well are the average of 3 independent experiments; , p < 0.05. (b) Microscopy
analysis showing that acidiﬁcation was sensitive to baﬁlomycin A1. Upper panel shows cells treated with DMSO (control): lysotracker
staining overlaps with S.aureus containing compartment whereas lower panel shows cells treated with baﬁlomycin A1, where overlap
between S.aureus and lysotracker is absent (images taken at 3.5 h post infection).
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Figure 5. Rab 14, PI3K-Akt axis and intracellular survival of S.aureus. (a) Absence of colocalization of S.aureus and Rab14 over a time
course (images were taken 1.5 h post infection). Cells were infected with GFP-S.aureus. Rab14 was stained with rabbit anti-Rab14 and
Rhodamine Red-conjugated donkey anti-rabbit (red) antibodies. Images are representative of triplicate coverslips in 3 independent
experiments. (b) Quantiﬁcation of intracellular bacteria in transfected MH-S with plasmid pcDNA3 or with Rab14 dominant negative
construct (DN Rab 14) over a time course. Cells were transfected 24 h before the experiment, and cells were infected as described above.
Data shown as c.f.u./well are the average of 3 independent experiments; , p < 0.05. (c) Percentage of colocalization of S.aureus with
TMR-dextran (red) over a time course (images were taken 3.5h post infection). Cells were transfected 24 h before the experiment with
DN Rab 14 and pcDNA3 constructs. Cells were pulse–chased with TMR-dextran, then infected and ﬁxed at the indicated times. S.aureus
was stained with rabbit anti-S.aureus and Cy2-conjugated donkey anti-rabbit (green) antibodies. (d) Immunoblot analysis of total Akt,
and Akt and AS160 phosphorylation (P-Akt and P-AS160) in lysates of MH-S infected with S.aureus for the indicated times. Detection of
Akt-Ser473 phosphorylation by Western blotting with rabbit anti-phosphoSer473 Akt and goat anti-rabbit conjugated to horseradish
peroxidase antibodies (ﬁrst panel). Detection of AS160 (Thr642) phosphorylation with rabbit anti-phosphoThr642 AS160 and goat anti-
rabbit conjugated to horseradish peroxidase antibodies (second panel). Detection of total Akt by Western blotting with rabbit anti- Akt
and goat anti-rabbit conjugated to horseradish peroxidase antibodies (third panel). Detection of tubulin was used as loading control
(fourth panel). LY294002 (75 mM) was added to the cells during gentamicin treatment and kept until the end of the experiment. Data
are representative of 3 independent experiments. (e) Quantiﬁcation of intracellular bacteria in MH-S infected with S.aureus, which were
mock-treated (black bar) or treated with Akt inhibitor X (10mM) or LY294002 (75 mM). Treatments were added after the time of contact,
during the gentamicin treatment and kept until cells were lysed for bacterial enumeration. Data, shown as c.f.u./well are the average of
3 independent experiments.
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least until 28 h post infection that corresponds to the
latest time point analyzed. During this time course,
Newman was able to replicate to a degree that bacte-
ricidal activity of macrophages was exceeded, as
shown by plating and microscopy counts after genta-
micin protection assays. During the ﬁrst hour post
infection, there is a decrease in the number of bacte-
ria recovered and this can be explained by the fact
that bacteria adhered, and not yet phagocyted are
eliminated by the action of gentamicin. In addition,
we cannot exclude the possibility that some macro-
phages might be able to counteract the infection pro-
cess in this early period of time. In fact, during the
second phase that goes till 16.5h post infection, bacte-
rial counts remain constant along time, suggesting
that there is a balance between macrophage bacteri-
cidal activity and S.aureus survival. Finally, and till
the last time point considered, intracellular bacterial
counts gradually increase indicating that S.aureus not
only remains viable, but that it is also able to repli-
cate efﬁciently inside the cell. In the same direction,
the number of bacteria per infected cell also increased
along time. It is important to mention that although
a certain degree of cytotoxicity was detected, the per-
centage of infected cell along time remained quite
similar. In a recent paper, authors demonstrated in a
murine model persistence inside alveolar macro-
phages.21 Similarly, Kubica M et al, found that S.
aureus was able to persist intracellularly inside human
monocyte-derived macrophages in vacuoles, before
escaping into the cytoplasm.20
In our study, once S.aureus has been internalized by
macrophages, it resides in a vacuolar compartment.
Intracellular trafﬁcking dynamics characterization has
covered the same sampling time points as the plating
experiment. The pathogen transits temporarily through
a compartment with early endosome features, being pos-
itive for EEA-1 during the ﬁrst 30 minutes post infection,
but colocalization rapidly decreased. Later, and till the
last time point analyzed, it acquires late endosome char-
acteristics,36 including the markers Lamp-1 and Rab7, as
well as its effector protein RILP. Jubrail J et al also found
that the majority of S.aureus containing compartments
were positive for Lamp-1 in macrophages infected with
Newman strain.21 Tranchemontagne ZR et al also
reported in differentiated THP-1 challenged with strain
USA300, Lamp-1 positive containing phagosomes.23
And ﬁnally, in RAW 264.7 also using strain USA 300,
authors also reported a high percentage of Lamp-1 coloc-
alization after 30 min of infection.22 In contrast, Seto
S et al, found that S.aureus viability decreased quickly in
RAW 264.7, showing no signs of intracellular survival or
proliferation.43 Authors reported a high proportion of
Rab7-positive S.aureus containing phagosomes, from the
early hours post-infection till 6h post infection.
S.aureus co-localized with lysotracker, indicator of
acidic organelles during all time course, indicating that
intracellular survival was indeed possible within an acidic
niche. This has also been reported in previous stud-
ies.22,44,45 Indeed, Leimer N et al found in A549 cells that
acidic environment facilitates the formation of non stable
small colony variants,46,47 that were able to persist within
lysosomes.48 In contrast, Jubrail J et al found that in dif-
ferentiated THP-1, Newman S.aureus was contained in
an endosome which failed to acidify correctly, despite
high intracellular bacterial burden.21 In our experience
S.aureus was able to survive inside the vacuole regardless
of the pH, as treatment with baﬁlomycin, which inhibits
vacuolar acidiﬁcation did not substantially decreased
intracellular counts. Therefore, the alteration of the niche
pH did not result bactericidal. Instead, Tranchemontage
ZR et al showed that the inhibition of phagosome acidiﬁ-
cation had a critical impact on USA300 strain survival,
and altered the expression of agr regulatory systems.23
The percentage of dextran colocalization reported
at 24.5 h post infection (»50%) is lower than previ-
ously reported.22 In that study, authors found percen-
tages of dextran colocalization around 70% at an
early time point (30 min post infection), both in
RAW 264.7 murine macrophages and primary human
M-CSF derived macrophages infected with USA300.
Some differences between both studies could explain
these differences: cell line, considering the origin
(human/murine), as well as the cell sub-type (alveo-
lar/peritoneal/ peripheral blood), strain (USA300/
Newman) and the time point selected (30 min/ time
course until 24.h post-infection).
In our experience, Rab 14 did not colocalize with S.
aureus containing phagosome at any time point consid-
ered. Seto et al found that colocalization with Rab14 had
a peak at 30 min and only lasted till 1h post infection.43
These data suggest that Rab14 recruitment can be tran-
sient, and thus difﬁcult to assess. In addition, Rab pro-
teins do not necessarily accumulate on vesicles to which
they contribute trafﬁcking, for example they can be local-
ized on vesicles delivered to phagosomes, without being
accumulating on the phagosome itself.49,50 Kyei GB et al
identiﬁed a critical role for the small GTPase Rab14 in
maintaining mycobacterial phagosome maturation
block, by inhibiting phagosome-late endosome fusion.41
Similarly, the role of Rab14 in phagosome maturation
has also been demonstrated in a Drosophila model with
S.aureus infection.51 In our experience, transfection with
a DNRab14 plasmid, overexpressing inactive Rab14
enabled an almost complete intracellular bacterial elimi-
nation. However, percentages of colocalization with
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TMR-dextran of 50% suggest that phagolysosomal fusion
might be somehow delayed, suggesting a slower kinetic.
Overall, these results might reﬂect a balance between
intracellular bacteria killing and intracellular bacteria
growth, and do not allow us to drawn ﬁrm conclusions.
PI3K-Akt axis is involved in bacterial intracellular
trafﬁcking. Kuijl et al demonstrated that Salmonella
typhimurium activates Akt to prevent phagosome-lyso-
some fusion, acting as a key regulator of at least 3
GTPases and 2 cell host pathways involved in intracellu-
lar survival.39 It has been described that Akt-1 phosphor-
ylates AS160, which main role is to activate in turn
GTPase Rab14.40 By western-blot analysis we showed
that S.aureus infection was able to activate both Akt and
AS160, and that total Akt expression was constant at all
time points.
Akt is also implicated in the intracellular survival of
others pathogens, such as M.tuberculosis, suggesting that
this kinase might be a central host factor targeted by
pathogens to take control over speciﬁc cellular func-
tions.40 Since S.aureus infection activated Akt in vitro,
we speculated that activated Akt may also promote intra-
cellular survival. However, Akt inhibition did not result
in a signiﬁcant decrease in bacterial intracellular counts,
suggesting that although the microorganism activates
PI3K-Akt pathway during phagocytosis, bacteria do not
aim it for intracellular survival. Further experiments are
needed to deﬁne and determine the mechanism by which
S. aureus modulates, and alters phagolysosomal matura-
tion process. This analysis, which cannot easily be
addressed, becomes very complex and it was not the
scope of the current study.
Different experimental studies have thus demon-
strated that S.aureus is able to persist within different
types of host cells holding a remarkable capacity of adap-
tation.16 There is a special emphasis placed on character-
izing phenol soluble modulins,44 a-toxin,52,53
leukocidins,54,55 and regulatory systems26 role during S.
aureus adaptation and intracellular survival. However,
survival mechanisms involved (whether in a vacuole or
in the cytoplasm, for example), as well as its intracellular
trafﬁcking (colocalization with endosomal/ ﬂuid
markers, phagosomal escape and pH conditions) are
highly dependent on cell origin (human or murine) and
sub-type (phagocytic and non phagocytic), bacterial
strain used and MOI considered, as well as growth phase
used for infection.56-58 So, all these factors need to be
carefully considered when comparing studies because
discrepancies might be reﬂecting important biologic dif-
ferences depending on the cell line and bacteria tested.
Long-term survival, especially inside professional
phagocytes may be a mechanism of dissemination with
important implications in treatment options; whereas
survival inside speciﬁc non-phagocytic cells, such as epi-
thelials, osteoblasts may contribute to chronic infections,
nasal carriage and/or transient colonization of skin and
mucous membranes. For example, some chronic and
therapy refractory staphylococcal infections, have been
associated with the presence of small colony variants,
which display an altered bacterial phenotype, adapted to
the intracellular environment revealing the evidence of
intracellular adaptation and persistence during human
infections.46,47,59
Further research exploring bacterial factors that con-
tribute to intracellular survival, and host factors leading
to S.aureus clearance or survival during lung infections
are poorly documented and are a rich area for future
research. The ability to survive and/or replicate intracel-
lularly together with its capacity of adaptation can con-
tribute signiﬁcantly to the global progression of the
staphylococcal infection. To establish and deﬁne which
mechanisms enable S.aureus to remain in an intracellular
stage in an experimental model is of crucial importance
as it opens new therapeutical approaches and at the
same time provides insights into the pathogenesis of
staphylococcal infections.
Material and methods
Bacterial strain and culture conditions
S.aureus Newman strain has been used extensively in
animal models of staphylococcal disease due to its robust
virulence phenotype.60 When indicated, a GFP-Newman
strain was used instead. Bacteria were grown in Luria-
Bertani (LB) at 37C on an orbital shaker (180 rpm). To
UV kill bacteria, samples were UV irradiated (1 J for
10 min) in a Bio-link Blx crosslinker (Vilber Lourmat).
Eukaryotic cell culture
Murine alveolar macrophages MH-S (ATTC, CRL-2019)
were grown on RPMI-1640 tissue culture medium sup-
plemented with 10% heat-inactivated calf serum (FCS),
Hepes 10mM and antibiotics/antifungals at 37C in an
humidiﬁed atmosphere and 5% CO2.
Infection of macrophages
Cells were seeded in 24-well tissue culture plates at
5 £ 105 cells per well 24h before the experiment. Bacteria
were grown in 5 ml of LB and harvested in the exponen-
tial phase (2500 x g, 20 min, 22C), washed once with
PBS, and resuspended using vortex and pipetting.
Absence of bacterial aggregates was checked visually. A
suspension containing approximately 1 £ 109 cfu/ml
was prepared in 10 mM PBS (pH 6.5). Cells were
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infected with 25 ml of this suspension to get a MOI of
25:1 in a ﬁnal volume of 500 ml RPMI 1640 tissue culture
medium supplemented with 10% FCS and Hepes 10
mM. To synchronize infection, plates were centrifuged at
200 £ g during 5 min. Plates were incubated at 37C in a
humidiﬁed 5% CO2 atmosphere. After 30 min of contact,
cells were washed 5 times with PBS and incubated for
1 hour with 500 ml RPMI 1640 containing 10% FCS,
Hepes 10 mM, gentamicin (200 mg/ml), followed by an
additional incubation of 1 hour (or more, depending on
interested time point) with 500 ml RPMI 1640 containing
10% FCS, Hepes 10 mM, gentamicin (25 mg/ml). The
same protocol was performed in the absence of gentamy-
cin (25 mg/ml) for the long-term incubation periods.To
determine intracellular bacterial load, cells were then
washed 3 times with PBS and lysed with 300 ml of
0.025% saponin in PBS for 10 min at room temperature.
Serial dilutions were plated on LB to quantify the num-
ber of intracellular bacteria. Data are represented as c.f.u.
per well. All experiments were done with triplicate sam-
ples at least on 3 independent occasions.
When exploring phagocytosis mechanisms, MH-S
were pre-incubated for 1 hour with nocodazole
(50mg/ml), nystatin (25 mg/ml), ﬁlipin (5 mg/ml),
LY294002 (75 mM) or for 30 min with Cyt D (5 mg/ml)
before carrying out infections as described above. Cells
were also pre-incubated with MbCD (1mM) for 1 hour,
washed twice with PBS to remove cholesterol and later
infected as described. When indicated, LY294002
(75 mM), Akt X (10 mM) or baﬁlomycin A1 (100 nM)
were added to the cells at the onset of the gentamicin
treatment and kept until the end of the experiments.
Exposure to these drugs had no effect on cell and bacte-
rial viability under the conditions tested. All drugs were
purchased from Sigma.
Neutral red assay and cell viability
Cell viability was determined by assessing the ability of
viable cells to incorporate and bind the supravital dye
neutral red in the lysosomes.29 MH-S were seeded on 96-
well tissue culture plates at 5 £ 105 cells/well 24 h before
the experiment. Cells were then infected with a MOI of
25:1 in a ﬁnal volume of 200 ml of RPMI-1640 culture
medium supplemented with 10% heat-inactivated FCS
and 10 mM Hepes. To synchronize infection, plates were
centrifuged at 200 x g during 5 min. Plates were incu-
bated at 37C in a humidiﬁed 5% CO2 atmosphere. After
30 min of contact, cells were washed twice with PBS and
incubated with 200 ml RPMI 1640 containing 10% FCS,
10 mM Hepes, gentamicin (200 mg/ml) during 6 h, 18 h
and 24 h. Alternatively, cells were incubated with genta-
micin (200 mg/ml) for 1 h, and later cells were incubated
with media without antibiotic during the selected time
points. After that, medium was aspirated and cells were
washed twice with PBS and later incubated with 100 ml
of freshly prepared neutral red medium at a ﬁnal concen-
tration of 40 mg/ml for 2 h. Wells were then washed once
with PBS and the remaining biomass-adsorbed neutral
red was dissolved with 150 ml neutral red destain solu-
tion (50% ethanol 96%, 49% deionised water, 1% glacial
acetic acid). Staining was quantiﬁed by determining the
OD at 540 nm in a microplate reader, and used to com-
pare the relative neutral red staining of uninfected cells,
infected cells and cells lysed completely with 1% Triton
X-100. Experiments were performed by triplicate in 3
independent occasions.
Generation of a rabbit polyclonal
anti-S.aureus serum
Rabbit anti-S.aureus serum was produced by Charles
River Laboratories through repeated immunization of
one rabbit with a mixture of acetone killed bacteria. This
mixture was obtained from an overnight-grown culture
of Newman strain, which was centrifuged, resuspended
in acetone to half of the original volume and agitated for
24 h. Acetone killed bacteria were centrifuged, resus-
pended in one-tenth of the original acetone volume and
agitated for 1 h. Finally, the suspension of acetone-killed
bacteria was dried with a vacuum desiccator.
Immunoﬂuorescence microscopy
Cells were seeded on 12 mm circular coverslips in 24-
well tissue culture plates. Infections were performed as
described before for intracellular bacterial counts. When
indicated, cells were washed 3 times with PBS, and ﬁxed
with 3.7% paraformaldehyde (PFA) in PBS (pH 7.4) for
15 min. For early endosome antigen 1 (EEA-1) staining,
cells were ﬁxed with 2.5% PFA for 10 min at room tem-
perature, followed by 5% PFA with 80% methanol at
¡20C for 5 min.
S.aureus was stained with rabbit polyclonal anti-S.
aureus serum diluted 1:500. Actin cytoskeleton was
stained with texas red-X-phalloidin (T 7471, Invitrogen)
diluted 1:200. Host cell nuclei was stained with Hoechst
33342 (Hoechst 33342, Invitrogen) diluted 1:2500. Early
endosomes were stained with goat anti-EEA1 antibody
(N-19; Santa Cruz Biotechnology) diluted 1:50. Late
endosomes were stained with rat anti-Lamp-1 (1D4B;
Developmental Studies Hybridoma Bank) diluted 1:150.
For the detection of Rab14, cells were infected with GFP-
Newman, using the same protocol as with Newman
strain. Anti-Rab14 (C-terminal) rabbit antibody was
used (Sigma, R0656) diluted 1:800. Donkey anti-rabbit,
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donkey anti-rat and donkey anti-goat secondary anti-
bodies conjugated to rhodamine, Cy5 or Cy2 were pur-
chased from Jackson Immunological and diluted 1:200.
Fixable dextran 70 000 MW labeled with Texas red
(TMR-dextran, D1864, Life technologies) was used to
label lysosomes in a pulse - chase assay, given that endo-
cytosed TMR-dextran is delivered and retained by endo-
cytic compartments. Brieﬂy, alveolar macrophages
seeded on glass coverslips were labeled by pulsing with
250 mg/ml TMR-dextran for 2 h at 37C in 5% CO2 in
culture medium. To allow the TMR-dextran to accumu-
late in lysosomes, medium was removed, and cells were
washed 3 times with PBS and incubated for 1h in dye-
free medium (chase). After the chase period, cells were
infected with live or UV-killed S.aureus as described
above. Acidic compartments were loaded with 0.5 mM
lysotracker (Red DND-99,Invitrogen), 45 min before
PFA ﬁxation. At the end of the infection period, the
residual ﬂuid marker was removed by washing the cells
3 times with PBS, followed by ﬁxation.
Staining was performed in 10% horse serum and 0.1%
saponin in PBS. Coverslips were washed twice in PBS con-
taining 0.1% saponin, once in PBS, and incubated for 30 min
with primary antibodies. Staining protocol for Rab14
included a permeabilization (PBS-saponin 0.4%, 10min) and
blocking (PBS-saponin 0.05%, 10% horse serum, 30 min)
step. Coverslips were then washed twice in 0.1% saponin in
PBS and once in PBS and incubated for 30 min with second-
ary antibodies. Finally, coverslips were washed twice in 0.1%
saponin in PBS, once in PBS and once in H2O, mounted on
Aqua Poly/Mount (18606, Polysciences).
Depending on the marker, S.aureus containing
compartment was considered positive when it fulﬁlled
these criteria: (i) the marker was detected throughout
the area occupied by the bacterium and (ii) the
marker was detected around/enclosing the bacterium
or (iii) the marker was concentrated in this area, in
comparison to the immediate surroundings. For each
individual infected cell, intracellular bacteria located
inside the compartment (positive colocalization) and
outside the compartment (negative) were recorded.
The percentage of positive colocalization was calcu-
lated as: total number of bacteria located in the com-
partment/ total number of intracellular bacteria
(regardless of being in the compartment or not). To
determine the percentage of bacteria that co-localized
with each marker, all bacteria located inside a mini-
mum of 100 infected cells were analyzed in each
experiment. Experiments were performed by triplicate
in 3 independent occasions. Specimens were observed
either on a Leica DM6000B epiﬂuorescence micro-
scope for quantitative analysis and a Leica TCS SP5
confocal microscope for image analysis.
Plasmids and transient transfection
For transient transfections with GFP-Rab 7,61 RILP-C33-
EGFP,30 pcDNA343 orDN-Rab14,43MH-S cells were seeded
in 24-well plates at a density of 3 £ 105 cells per well 24 h
before the experiment. Cells were transfected with 750 ng of
DNAusingXfect TransfectionReagent (Clontech) following
the manufacturer’s instructions. Twenty-four hours post-
transfection cells were infected as indicated. In all cases, cells
were ﬁxed, stained and later analyzed by immunoﬂuores-
cence microscopy. After 24 h, cells were washed twice with
PBS, infected and intracellular bacterial loadwas determined
as described previously.
Detection of total Akt, P-Akt and P-AS160
by Western blotting
MH-S were seeded on 6-well tissue culture plates at
2 £ 106 cells/well. Cells were infected as described previ-
ously. At indicated time points, cells were washed 3 times
with cold PBS, scraped and lysed with 100 ml lysis buffer
(1 £ SDS Sample Buffer, 62.5 mM Tris-HCl pH 6.8, 2%
w/v SDS, 10% glycerol, 50 mM DTT, 0.01% w/v bromo-
phenol blue) on ice. Samples were sonicated, boiled at
100C for 10 min and cooled on ice before polyacryl-
amide gel electrophoresis and Western Blotting.
Total Akt and Akt and AS160 phosphorylation
(P-Akt, P-AS160) were detected with primary rabbit anti
Akt (Akt1, Akt2 and Akt3), primary rabbit anti-phospho
Ser473 Akt and primary rabbit anti-phospho Thr642
AS160 antibodies (Cell Signaling Technology) diluted
1:1.000 and with secondary goat anti-rabbit antibody
conjugated to horseradish peroxidase (Thermo Scien-
tiﬁc) diluted 1:10,000. Tubulin was detected with pri-
mary mouse anti-tubulin antibody (Sigma) diluted
1:3000 and secondary goat anti-mouse antibody (Pierce)
conjugated to horseradish peroxidase diluted 1:1,000. To
detect tubulin, membranes were reprobed after stripping
of previously used antibodies using Western Blot Strip-
ping Buffer (Thermo Scientiﬁc). Images were recorded
with a GeneGnome HR imaging system (Syngene).
Statistical analysis
Statistical analyses were performed using the 2-tailed
unpaired t-test (2 groups) or ANOVA (multiple groups).
P < 0.05 was considered statistically signiﬁcant. The
analyses were performed using GraphPad Prism 5
(Graph Pad Software).
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